Oxytetracycline is a tetracycline antibacterial used widely in livestock and for selected equine infections. Its spectrum includes susceptible conventional and intracellular organisms, with applications such as bovine respiratory disease, anaplasmosis and Potomac horse fever. A separate non-antibacterial application is treatment of selected neonatal foal flexural limb deformities.
Group
Tetracycline antibacterial
Mechanism of Action
Oxytetracycline reversibly binds the bacterial 30S ribosomal subunit and blocks aminoacyl-transfer RNA access, inhibiting protein synthesis and usually producing bacteriostatic activity. In foals, proposed effects on matrix-metalloproteinase expression, myofibroblast activity and collagen organization can reduce tendon-associated contracture. That non-antibacterial mechanism is incompletely defined and is distinct from its ribosomal target.
Dose Rates
Dogs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Bacterial infection | 7.5–10 mg/kg | IV | Every 12 h | |
| Bacterial infection | 20 mg/kg | PO | Every 12 h | |
| Bacterial infection | 22 mg/kg | PO | Every 8 h | Up to 14 days |
| Bacterial infection | 20 mg/kg | PO | Every 8–12 h | |
| Depot antibacterial treatment | 20 mg/kg | IM | Every 168 h | Repositol formulation specifically; do not apply to conventional injection. |
| Salmon poisoning adjunct | 7 mg/kg | IV | Every 8 h | Up to 5 days; Reported course 3-5 days. |
| Antibiotic-responsive diarrhea | 10–20 mg/kg | PO | Every 8 h |
Cats
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Bacterial infection | 7.5–10 mg/kg | IV | Every 12 h | |
| Bacterial infection | 20 mg/kg | PO | Every 12 h | |
| Hemotropic mycoplasmosis | 10–25 mg/kg | PO, IV | Every 8 h | Up to 7 days; Reported 5-7 days; persistent infection can remain. |
| Bacterial infection | 20 mg/kg | PO | Every 8–12 h | |
| Inflammatory bowel disease antibiotic trial | 10–20 mg/kg | PO | Every 8 h |
Horses
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Rickettsial and other susceptible infection | 10 mg/kg | IV, IM | Every 24 h | Slow IV administration; IM use may cause pain and local reactions. |
| Piroplasmosis | 5–6 mg/kg | IV | Every 24 h | Up to 7 days |
| Flexural limb deformity | 44 mg/kg | IV | Every 24 h | Up to 2 days; Foals only; give slowly. Two doses 24 hours apart. Reported regimen describes escalation up to 70 mg/kg and approximately 2-3 g/foal. |
| Flexural limb deformity | 70 mg/kg | IV | Every 24 h | Up to 2 days; Higher reported foal regimen; give slowly and reassess before the second dose. |
| Foal bacterial infection | 5–10 mg/kg | IV | Every 12 h | Foals; dilute and administer slowly. |
| Foal bacterial infection | 10–20 mg/kg | IV | Every 24 h | Foals; dilute and administer slowly. |
| Rickettsial infection | 6.6 mg/kg | IV | Every 24 h | Dilute at least 1:1; administer slowly or in 500-1000 mL fluid. |
| Lyme disease | 5–6.6 mg/kg | IV | Every 12 h | Up to 28 days; Reported 3-4 week course. |
| Potomac horse fever | 6.6 mg/kg | IV | Every 12 h | Up to 5 days; Usually no more than 5 days. |
| Proliferative enteropathy in foals | 5–6.6 mg/kg | IV | Every 12 h | Up to 7 days; Initial 3-7 days then doxycycline 10 mg/kg PO every 12 hours for 7-17 days. |
| Proliferative enteropathy combination | 10–18 mg/kg | IV | Every 24 h | Slow IV with metronidazole 10-15 mg/kg PO every 8-12 hours. |
Cattle
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Enteric bacterial infection in calves | 11 mg/kg | PO | Every 24 h | |
| Pneumonia in calves | 11 mg/kg | PO | Every 12 h | |
| Systemic bacterial infection | 11 mg/kg | IV | Every 12 h | |
| Long-acting antibacterial treatment | 20 mg/kg | IM | Once | Long-acting formulation only. |
| Long-acting product antibacterial treatment | 20–30 mg/kg | IM | Every 72–120 h | Do not use in: Established renal insufficiency; Oxy-LA 200 mg/mL product: repeat after 3-5 days if necessary; deep IM. Meat withdrawal 30 days, milk 14 days. |
| Long-acting antibacterial treatment | 20 mg/kg | SC | Once | LA-200 formulation. |
| Bacterial infection with conventional schedule | 6.6–11 mg/kg | IM, SC, IV | Every 24 h | Up to 4 days; Product-specific label alternative; slow IV over at least 5 minutes when specified; reassess within 24-48 hours. |
| Respiratory disease control | 30 mg/kg | IM, SC | Once | 300 mg/mL Tetradure formulation. |
| Pneumonia or infectious keratoconjunctivitis | 20–30 mg/kg | IM, SC | Once | 300 mg/mL product-specific alternative. |
| Respiratory bacterial infection | 11 mg/kg | IM, SC | Every 24 h | 50 mg/mL conventional injection. |
| Respiratory bacterial infection | 11 mg/kg | IV | Every 12–24 h | 50 mg/mL conventional injection. |
| Respiratory bacterial infection | 20 mg/kg | IM | Every 24 h | 100 mg/mL product. |
| Respiratory bacterial infection | 20 mg/kg | IM | Every 72–96 h | 200 mg/mL long-acting product. |
| Anthrax | 4.4 mg/kg | IM, IV | Every 24 h | May negate a recent live anthrax vaccination in healthy animals. |
| Anaplasmosis carrier treatment | 22 mg/kg | IM, IV | Every 24 h | Up to 5 days; Conventional 50/100 mg/mL product; IV diluted in saline, IM no more than 10 mL/site. |
| Anaplasmosis carrier treatment | 11 mg/kg | IM, IV | Every 24 h | Up to 10 days; Conventional 50/100 mg/mL product; IV diluted in saline, IM no more than 10 mL/site. |
| Anaplasmosis carrier treatment | 20 mg/kg | IM | Every 72 h | Depot formulation, four treatments in divided deep-IM sites. |
| Anaplasmosis herd protection | 6.6–11 mg/kg | IM | Every 504–672 h | Conventional formulation during vector season, extending 1-2 months afterwards. |
| Anaplasmosis herd protection | 20 mg/kg | IM | Every 672 h | Depot formulation alternative. |
| Pneumonia | 11 mg/kg | SC | Every 24 h | |
| Pneumonia | 20 mg/kg | IM | Every 48 h | Depot formulation. |
Pigs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Bacterial infection | 6.6–11 mg/kg | IM | Every 24 h | |
| Bacterial infection | 10–20 mg/kg | IM | Every 24 h | |
| Bacterial infection | 20 mg/kg | IM | Every 48 h | |
| Long-acting product antibacterial treatment | 20 mg/kg | IM | Every 72–120 h | Oxy-LA product; a second dose may be required after 3-5 days. |
| Anthrax | 4.4 mg/kg | IM, IV | Every 24 h | May negate a recent live anthrax vaccination in healthy animals. |
| Sow periparturient enteritis control | 6.6 mg/kg | IM | Once | 300 mg/mL product: about 8 hours before farrowing or immediately after completion. |
| Bacterial infection | 10–20 mg/kg | PO | Every 6 h | |
| Conventional injection antibacterial treatment — Initial | 10 mg/kg | IM | Once | |
| Conventional injection antibacterial treatment — Maintenance | 7.5 mg/kg | IM | Every 24 h |
Buffalo
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Long-acting product antibacterial treatment | 20–30 mg/kg | IM | Every 72–120 h | Do not use in: Established renal insufficiency; Oxy-LA 200 mg/mL product: repeat after 3-5 days if necessary; deep IM. Meat withdrawal 30 days, milk 14 days. |
Camel
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Long-acting product antibacterial treatment | 20–30 mg/kg | IM | Every 72–120 h | Do not use in: Established renal insufficiency; Oxy-LA 200 mg/mL product: repeat after 3-5 days if necessary; deep IM. Meat withdrawal 30 days, milk 14 days. |
Sheep
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Long-acting product antibacterial treatment | 20–30 mg/kg | IM | Every 72–120 h | Do not use in: Established renal insufficiency; Oxy-LA 200 mg/mL product: repeat after 3-5 days if necessary; deep IM. Meat withdrawal 30 days, milk 14 days. |
| Anthrax | 4.4 mg/kg | IM, IV | Every 24 h | May negate a recent live anthrax vaccination in healthy animals. |
| Enteritis or pneumonia | 22 mg/kg | PO | Every 24 h | Up to 14 days; In drinking water for 7-14 days. |
Goat
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Long-acting product antibacterial treatment | 20–30 mg/kg | IM | Every 72–120 h | Do not use in: Established renal insufficiency; Oxy-LA 200 mg/mL product: repeat after 3-5 days if necessary; deep IM. Meat withdrawal 30 days, milk 14 days. |
| Anthrax | 4.4 mg/kg | IM, IV | Every 24 h | May negate a recent live anthrax vaccination in healthy animals. |
| Enteritis or pneumonia | 22 mg/kg | PO | Every 24 h | Up to 14 days; In drinking water for 7-14 days. |
Poultry
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Long-acting product antibacterial treatment | 30–60 mg/kg | IM | Every 72–120 h | Oxy-LA product instruction derived from 0.15-0.30 mL/kg at 200 mg/mL; no egg withdrawal supplied. |
Rabbits
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible infection | 15 mg/kg | SC, IM | Every 8 h | |
| Susceptible infection | 15–50 mg/kg | PO | Every 24 h | |
| Reported E. cuniculi adjunct | 20 mg/kg | SC | Every 24 h | Historical reported use; efficacy is not established by this dose listing. |
Chinchillas
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible infection | 50 mg/kg | PO | Every 12 h |
Gerbils
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible infection | 10 mg/kg | PO | Every 8 h | |
| Susceptible infection | 20 mg/kg | SC | Every 24 h |
Guinea pigs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible infection | 50 mg/kg | PO | Every 12 h |
Hamsters
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible infection | 16 mg/kg | SC | Every 24 h |
Mice
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible infection | 10–20 mg/kg | PO | Every 8 h |
Rats
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible infection | 10–20 mg/kg | PO | Every 8 h | |
| Susceptible infection | 6–10 mg/kg | IM | Every 12 h |
Birds
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chlamydiosis | 50 mg/kg | IM | Every 72–120 h | 200 mg/mL depot product; severe local tissue reactions possible. |
| Chlamydiosis outbreak control | 200 mg/kg | IM | Every 24 h | Up to 5 days; Separate historical 3-5 day report with oral tetracycline transition; high exposure and local injury risk require species-specific assessment. |
Reptiles
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible infection | 10 mg/kg | PO | Every 24 h | Up to 7 days; Turtles and tortoises; reported ulcerative stomatitis use. |
Indications
- Treatment of susceptible livestock respiratory, wound, soft-tissue or selected enteric infections with a corresponding veterinary product.
- Treatment of bovine anaplasmosis caused by susceptible Anaplasma marginale.
- Treatment of selected infectious bovine keratoconjunctivitis caused by susceptible organisms.
- Treatment of Potomac horse fever and selected other equine intracellular bacterial infections, including supported anaplasmosis or proliferative enteropathy regimens.
- Treatment of selected avian chlamydial infections with a species-appropriate regimen.
- Specialist treatment of selected flexural limb deformities in neonatal foals.
Contraindications
- Prolonged treatment in growing animals may discolor teeth.
- Large IM volumes cause local injury.
Interactions
- Chelates calcium, iron, aluminum and magnesium; these can reduce absorption or cause incompatibility.
Adverse effects
- Injection pain, diarrhea or colic in horses, feline drug fever; excessive doses can cause renal or hepatic injury and metabolic abnormalities.
Toxicity
Excess exposure can cause gastrointestinal disease, renal accumulation and rumen stasis. Rapid IV tetracycline or propylene-glycol vehicle can provoke collapse, arrhythmias or hemolysis; dilution and slow administration are important.
Preparations
| Preparation | Form | Strength | Route |
|---|---|---|---|
| Oxytetracycline injection 100 mg/mL | Injection | 100 mg / mL | IV, IM |
| Oxytetracycline injection 200 mg/mL | Injection | 200 mg / mL | IV, IM |
| Oxytetracycline 250 mg | Tablet | 250 mg / tablet | PO |
| Oxytetracycline 500 mg | Tablet | 500 mg / tablet | PO |
| Oxy-LA injection 200 mg/mL Selmore Pharmaceuticals Oxytetracycline equivalent as HCl; long-acting deep IM product. Shake before use; do not use with established renal insufficiency. Product withdrawal: meat 30 days, milk 14 days. | Injection | 200 mg / mL | IM |
| Oxytetracycline conventional injection 50 mg/mL | Injection | 50 mg / mL | IV, IM, SC |
| Oxytetracycline 300 mg/mL long-acting injection Tetradure-type source presentation; IV use only when the exact product instructions authorize it. | Injection | 300 mg / mL | IM, SC |
| Terramycin oxytetracycline/polymyxin B ophthalmic ointment Sterile ocular ointment contains oxytetracycline HCl 5 mg and polymyxin B sulfate activity 10000 IU per gram; no single-component calculator opt-in. | Other | oxytetracycline hydrochloride 5 mg / g + polymyxin b 10000 IU / g | TOPICAL |
Monitoring and Administration
Conventional and long-acting injections require different schedules; long-acting behavior does not apply to IV administration. Limit IM volume to 10 mL/site in cattle and 5 mL/site in pigs.
Inject IV slowly and monitor hydration, renal function and gastrointestinal signs. Use diluted injection immediately; protect stock from light.
Unnormalized local protocols include equine intrauterine 1-5 g using povidone-based products only. Canine tear-staining reports use 25-50 mg/day with two-week on/off cycles; antimicrobial stewardship and uncertain benefit limit this indication. Pregnant-ewes campylobacteriosis and some bovine anaplasmosis/listeriosis lines lack an explicit route; they are not assigned one.